Privia Health Group, Inc.: directors' dealings · United States · SEC (Form 4)

About Privia Health Group, Inc.

Privia Health Group, Inc. (ticker: PRVA) is a U.S.-listed healthcare company trading on the NASDAQ market in the United States. Privia is best understood as a physician-enablement platform rather than a traditional provider or insurer. Its model is built to help physicians, medical groups, health plans, and health systems deliver better coordinated care, improve patient outcomes, and lower total healthcare costs. The company combines regional medical groups, physician-led governance, management services organizations, and a cloud-based technology and analytics stack that supports population health, workflow efficiency, care-gap management, and value-based care execution. Founded in 2007, Privia has grown from a regional physician platform into a national organization. Its headquarters are in Arlington, Virginia, which places the company close to major U.S. healthcare policy, payer, and provider networks. Over time, Privia expanded beyond its Mid-Atlantic roots into multiple U.S. markets, including Virginia, Maryland, and Washington, D.C., as well as Georgia, Texas, Florida, Tennessee, California, Montana, Ohio, North Carolina, Connecticut, Washington state, South Carolina, and Indiana. That geographic expansion reflects a deliberate market-by-market rollout strategy, with local operating structures adapted to each state’s regulatory and payer environment. The company’s core business lines center on organizing primary-care and multi-specialty physician practices, providing practice management support, and enabling participation in value-based care arrangements. Through local MSOs and associated medical groups, Privia supports provider contracting, reimbursement negotiations, patient records management, and population-health programs. It also participates in accountable care organization structures, including Privia-owned ACOs, allowing the company to monetize performance-based reimbursement models and deepen its involvement in Medicare and commercial value-based care. In practical terms, Privia’s competitive advantage lies in offering physicians scale, operational infrastructure, and technology while preserving a high degree of clinical autonomy. Competitively, Privia sits in an attractive but demanding segment of U.S. healthcare services. It competes for physician affiliation, payer relationships, and market share in value-based care, where execution quality and local physician trust matter as much as technology. Its platform approach differentiates it from pure administrative outsourcing models, while its physician-led structure helps support retention and practice engagement. Recent developments have reinforced the investment case. In 2025, Privia reported strong financial and operating momentum, including revenue growth, improved operating profit, and continued additions of implemented providers and attributed lives. The company also announced an agreement in September 2025 to acquire an ACO business from Evolent Health, expanding its value-based care footprint and adding attributed lives across commercial, Medicare, Medicare Advantage, and Medicaid arrangements. For investors, PRVA is a healthcare technology-and-services compounder listed on NASDAQ in the United States, with exposure to the secular shift toward coordinated care, risk-bearing provider models, and physician-led network consolidation.